use
pseudomonas
aeruginosa
vaccine
pateints
acute
leukemia
cystic
fibrosis
heptavalent
lipopolysaccharide
pseudomonas
vaccine
evaluated
patients
acute
leukemia
patients
cystic
fibrosis
month
interval
clinical
center
national
institutes
health
patients
excellent
serum
hemagglutinating
ha
antibody
response
immunization
comparison
patients
cystic
fibrosis
patients
leukemia
smaller
ha
antibody
response
lasted
shorter
period
time
also
experienced
greater
toxicity
vaccine
mixing
adrenal
corticosteroids
vaccine
greatly
decreased
side
reactions
among
patients
leukemia
without
significantly
inhibiting
antibody
production
previous
antineoplastic
chemotherapy
little
influence
antibody
response
patients
leukemia
exception
methortrexate
vaccinated
patients
leukemia
pseudomonas
infection
bacterial
fungal
infections
whereas
pseudomonas
infections
bacterial
fungal
infections
occurred
control
group
patients
acute
leukemia
patients
cystic
fibrosis
pseudomonas
infection
vaccination
